Ping An Biomedical Co

Ping An Biomedical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ping An Biomedical Co (PASW) as of Nov 20, 2026 is -2,000.00 CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 612,500.00 CNY — a change of -100.33% (lower).

EBITDA

-2,000.00CNY

YoY

-100.33%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ping An Biomedical Co is 2024 -2,000.00 CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ping An Biomedical Co was 2023 612,500.00 CNY. It decreases by -100.33% lower compared to the previous year.

The Ping An Biomedical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
10.82 M CNY
Jan 1, 2023
612,500.00 CNY
Jan 1, 2024
-2,000.00 CNY
The Ping An Biomedical Co EBITDA history
YEAREBITDAYoY
-2,000.00CNY-100.33%
612,500.00CNY-94.34%
10.82 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ping An Biomedical Co Stock analysis

What does Ping An Biomedical Co do? Majestic Ideal Holdings Ltd. generates revenue by providing supply chain management services within the apparel industry. The firm delivers one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. These services cover functions within the supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company employs 7 full-time employees to support these operations. The business is organized into two distinct segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles, and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. Through these segments, the firm provides end-to-end supply chain solutions to its clients. Ping An Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ping An Biomedical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ping An Biomedical Co is -2,000.00 CNY in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ping An Biomedical Co changed from 612,500.00 CNY to -2,000.00 CNY, representing a -100.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ping An Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ping An Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ping An Biomedical Co

All Key Metrics — Ping An Biomedical Co